Effect of repaglinide and gliclazide on glycaemic control, early-phase insulin secretion and lipid profiles in newly diagnosed type 2 diabetics.
Phase of Trial: Phase II
Latest Information Update: 01 Jan 2011
At a glance
- Drugs Gliclazide (Primary) ; Repaglinide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 05 Nov 2010 New trial record.